Latest Strategy News

Peet Limited has appointed its long-serving CFO Brett Fullarton as Interim CEO effective immediately, ahead of the planned departure of CEO Brendan Gore on 1 July 2025. This move aims to ensure a smooth leadership transition while a permanent CEO search is underway.

Enlitic, Inc. has launched a A$10 million placement alongside an offer of 125 million unquoted options, aiming to fuel growth in its AI-driven healthcare technology business. The move underscores both funding ambitions and the complex risks tied to AI adoption and market dynamics.

EQ Resources reports promising preliminary tungsten recovery results from Wolfram Camp stockpiles, achieving an 86% recovery rate and validating advanced X-ray sorting technology. This breakthrough supports the company’s vision for a low-impact regional tungsten hub in Queensland.

Cobre Limited has secured $500,000 through a placement and is now launching a fully underwritten Loyalty Options Rights Issue to raise approximately AU$1.18 million, supporting its capital-light, catalyst-rich copper exploration strategy in Botswana.

EQ Resources reports promising preliminary results from tungsten stockpile testing at Wolfram Camp, achieving an 86% recovery rate using advanced X-ray sorting technology. The company is advancing plans for a regional tungsten hub to enhance operational efficiency and sustainability.

WCM Global Growth Limited has renewed its on-market share buy-back program for 12 months, signaling ongoing confidence in its capital management strategy amid evolving market conditions.

NH3 Clean Energy reports strong Pre-FEED results for its WAH2 clean ammonia project, highlighting robust economics and strategic partnerships while facing key risks around gas supply and funding.

Invion Limited launches a Loyalty Option entitlement offer aimed at raising up to $16 million to support its advancing cancer clinical trials, including a promising anogenital cancer study with Peter MacCallum Cancer Centre.

New World Resources has successfully completed a placement of 32 million shares at $0.02 each to its board and senior management, following shareholder approval. This move subtly reshapes the company’s capital structure ahead of its copper and base metals projects in the US.

CLINUVEL Pharmaceuticals announces the full-time return of Managing Director Dr Philippe Wolgen, focusing on advancing critical product development and corporate initiatives, while Acting CEO Lachlan Hay continues until September 2025.

Thrive Tribe Technologies has announced a proposed 20, 1 share consolidation aimed at streamlining its capital structure, pending shareholder approval at the upcoming Extraordinary General Meeting.

Qualitas Real Estate Income Fund has declared its May 2025 distribution, offering investors a 7.42% annualized return based on net tangible assets. The fund continues to focus on Australian real estate loans secured by mortgages.